Quoin Pharmaceuticals, Ltd.
NASDAQ: QNRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael Myers
- Employees
- 3
- Headquarters
- Ashburn, United States
- IPO year
- 2016
- Market cap
- $7.7M
- Website
- https://quoinpharma.com
Loading QNRX…
Loading profile data…Frequently asked questions about QNRX
What does Quoin Pharmaceuticals, Ltd. (QNRX) do?
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of...
Where does QNRX trade?
Quoin Pharmaceuticals, Ltd. (QNRX) trades on the NASDAQ Capital Market.
What sector is QNRX in?
Quoin Pharmaceuticals, Ltd. (QNRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Quoin Pharmaceuticals, Ltd.?
Michael Myers is the chief executive officer of Quoin Pharmaceuticals, Ltd. (QNRX).
Where is Quoin Pharmaceuticals, Ltd. headquartered?
Quoin Pharmaceuticals, Ltd. is headquartered in United States.
Does QNRX pay a dividend?
Quoin Pharmaceuticals, Ltd. (QNRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QNRX go public?
Quoin Pharmaceuticals, Ltd. (QNRX) completed its initial public offering in 2016.
Is QNRX an ADR?
Yes — QNRX is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Quoin Pharmaceuticals, Ltd. reporting and dividends follow the underlying issuer.